{"id":23893,"date":"2017-05-25T09:00:48","date_gmt":"2017-05-25T07:00:48","guid":{"rendered":"http:\/\/cms.munich-startup.net\/?p=23893"},"modified":"2017-05-24T15:07:51","modified_gmt":"2017-05-24T13:07:51","slug":"pieris-pharmaceuticals-lands-billion-dollar-deal","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/23893\/pieris-pharmaceuticals-lands-billion-dollar-deal\/","title":{"rendered":"Pieris Pharmaceuticals lands billion-dollar deal"},"content":{"rendered":"

Good news from Freising: The biotechnology company Pieris Pharmaceuticals GmbH \u2014 a spin-off from the Technical University of Munich in 2001 \u2014 has closed a billion-euro deal with the British-Swedish pharmaceutical company AstraZeneca. As an upfront payment, the Freising-based company will receive IZB<\/a> The company, based in the United States, is investing approximately $58 million. Additional milestone payments could potentially increase this total to over $2 billion.
\n<\/strong><\/p>\n

Until then, the new partners want to use the Anticalin platform from Pieris<\/a> to evaluate their suitability for developing inhalable drugs for a range of indications. Part of the agreement is Pieris' preclinical lead drug candidate PRS-060 for asthma, an anticalin targeting the interleukin-4 receptor alpha. A Phase I trial is scheduled to begin in 2017, and four other anticalins are also being investigated in the area of lung diseases. Anticalins are antibody-like, but much smaller, protein molecules with specific binding properties.<\/p>\n

Maximizing potential together<\/h3>\n

Loud Stephen Yoder<\/strong>, President and CEO of Pieris, the partnership with AstraZeneca accelerates Pieris' transformation into a fully integrated drug development company with two main areas of immunotherapy: respiratory diseases and immuno-oncology:<\/p>\n

"We recognize AstraZeneca's unparalleled expertise in developing inhaled medicines. It will help maximize the potential of PRS-060 and other anticalin molecules."<\/p><\/blockquote>\n

Pieris recently attracted attention at the beginning of the year with a strategic partnership with SERVIER, France's largest pharmaceutical company. The company also has long-standing collaborations with pharmaceutical companies such as Sanofi and Daiichi Sankyo. Through a reverse merger with a US company, Pieris achieved a US stock exchange listing in 2015, which was eventually converted into a NASDAQ listing. For this purpose, the company's nominal headquarters are located in Boston, USA. The larger R&D branch, currently with over 40 employees, remains active in Freising near Munich.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Good news from Freising: The biotechnology company Pieris Pharmaceuticals GmbH\u2014a 2001 spin-off from the Technical University of Munich\u2014has closed a billion-dollar deal with the British-Swedish pharmaceutical company AstraZeneca. The company, based at the Freising IZB, will receive approximately $58 million as an upfront payment. Potential additional milestone payments could increase this...<\/p>","protected":false},"author":24,"featured_media":13666,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[52,2515],"acf":[],"yoast_head":"\nPieris Pharmaceuticals zieht Milliarden-Deal an Land - Munich Startup<\/title>\n<meta name=\"description\" content=\"Die Biotechnologie-Firma Pieris Pharmaceuticals GmbH konnte einen Milliardendeal mit dem Pharmakonzern AstraZeneca abschlie\u00dfen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/23893\/pieris-pharmaceuticals-lands-billion-dollar-deal\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pieris Pharmaceuticals zieht Milliarden-Deal an Land - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Die Biotechnologie-Firma Pieris Pharmaceuticals GmbH konnte einen Milliardendeal mit dem Pharmakonzern AstraZeneca abschlie\u00dfen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/23893\/pieris-pharmaceuticals-lands-billion-dollar-deal\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-25T07:00:48+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/\",\"url\":\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/\",\"name\":\"Pieris Pharmaceuticals zieht Milliarden-Deal an Land - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\",\"datePublished\":\"2017-05-25T07:00:48+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"Die Biotechnologie-Firma Pieris Pharmaceuticals GmbH konnte einen Milliardendeal mit dem Pharmakonzern AstraZeneca abschlie\u00dfen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\",\"width\":850,\"height\":566,\"caption\":\"Eisbach Bio Pieris Pharmaceuticals Finanzierung\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pieris Pharmaceuticals zieht Milliarden-Deal an Land\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"850\" \/>\n\t<meta property=\"og:image:height\" content=\"566\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pieris Pharmaceuticals lands billion-dollar deal - Munich Startup","description":"The biotechnology company Pieris Pharmaceuticals GmbH was able to conclude a billion-dollar deal with the pharmaceutical company AstraZeneca.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/23893\/pieris-pharmaceuticals-lands-billion-dollar-deal\/","og_locale":"en_US","og_type":"article","og_title":"Pieris Pharmaceuticals zieht Milliarden-Deal an Land - Munich Startup","og_description":"Die Biotechnologie-Firma Pieris Pharmaceuticals GmbH konnte einen Milliardendeal mit dem Pharmakonzern AstraZeneca abschlie\u00dfen.","og_url":"https:\/\/cms.munich-startup.net\/en\/23893\/pieris-pharmaceuticals-lands-billion-dollar-deal\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2017-05-25T07:00:48+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/","url":"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/","name":"Pieris Pharmaceuticals lands billion-dollar deal - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","datePublished":"2017-05-25T07:00:48+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"The biotechnology company Pieris Pharmaceuticals GmbH was able to conclude a billion-dollar deal with the pharmaceutical company AstraZeneca.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","width":850,"height":566,"caption":"Eisbach Bio Pieris Pharmaceuticals Finanzierung"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/23893\/pieris-pharmaceuticals-zieht-milliarden-deal-an-land\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Pieris Pharmaceuticals zieht Milliarden-Deal an Land"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":850,"height":566,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/08\/izb-eingang.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1495631184:3","_edit_last":"3","_yoast_wpseo_focuskw":"Pieris","_yoast_wpseo_metadesc":"Die Biotechnologie-Firma Pieris Pharmaceuticals GmbH konnte einen Milliardendeal mit dem Pharmakonzern AstraZeneca abschlie\u00dfen.","_yoast_wpseo_linkdex":"85","_thumbnail_id":"13666","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"Pieris","_yoast_wpseo_content_score":"90","ms_image_format":"","_ms_image_format":"","ms_dachzeile":"","_ms_dachzeile":"","ms_bump_post_date":"","_ms_bump_post_date":"","guest_author_name":"","_guest_author_name":"","guest_author_image":"","_guest_author_image":"","guest_author_description":"","_guest_author_description":"","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/23893"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=23893"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/23893\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/13666"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=23893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=23893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=23893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}